Usefulness of four dimensional (4D) PET/CT imaging in the evaluation of thoracic lesions and in radiotherapy planning: Review of the literature.
In the past decade, Positron Emission Tomography (PET) has become a routinely used methodology for the assessment of solid tumors, which can detect functional abnormalities even before they become morphologically evident on conventional imaging. PET imaging has been reported to be useful in characterizing solitary pulmonary nodules, guiding biopsy, improving lung cancer staging, guiding therapy, monitoring treatment response and predicting outcome. This review focuses on the most relevant and recent literature findings, highlighting the current role of PET/CT and the evaluation of 4D-PET/CT modality for radiation therapy planning applications. Current evidence suggests that gross tumor volume delineation based on 4D-PET/CT information may be the best approach currently available for its delineation in thoracic cancers (lung and non-lung lesions). In our opinion, its use in this clinical setting is strongly encouraged, as it may improve patient treatment outcome in the setting of radiation therapy for cancers of the thoracic region, not only involving lung, but also lymph nodes and esophageal tissue. Literature results warrants further investigation in future prospective studies, especially in the setting of dose escalation.
['Sindoni|Alessandro|A|', 'Minutoli|Fabio|F|', 'Pontoriero|Antonio|A|', 'Iatì|Giuseppe|G|', 'Baldari|Sergio|S|', 'Pergolizzi|Stefano|S|']
D004938:Esophageal Neoplasms D019788:Fluorodeoxyglucose F18 D056973:Four-Dimensional Computed Tomography D006801:Humans D008175:Lung Neoplasms D009367:Neoplasm Staging D000072078:Positron Emission Tomography Computed Tomography D011880:Radiotherapy Planning, Computer-Assisted D013899:Thoracic Neoplasms
Lung cancer Radiation therapy Four dimensional PET/CT